Yeah will be a long and bumpy road ahead I imagine. I think they may have built a few months in to compensate for any covid delays.
I really wish this trial had been set up as the last trial as far as a second cycle and length but I do feel that we'll have enough data, if we see similar score improvements, to petition the FDA for some type of drug approval. I also think this will give us the time get the synthetic drug equivalency proven. There is a very interesting Youtube video of the CEO of bryologyX and all the research they are doing and will be of huge cost savings to us as far as FDA synthetic acceptance is concerned. As most know we have been collaborating with them, especially on the pediatric cancer trial.
News 
Market Data 
Discover 
